Cantor Fitzgerald

Type

Other

Status

Active

Location

New York, United States

Total investments

15

Average round size

69M

Portfolio companies

13

Rounds per year

0.19

Lead investments

2

Follow on index

0.07

Exits

7

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsBig DataMedical DeviceMedicalPharmaceuticalEnergyRenewable EnergyNatural Resources

Summary

In 1945 was created Cantor Fitzgerald, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the New York. The venture was found in North America in United States.

The current fund was established by Steve Kantor.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Cantor Fitzgerald, startups are often financed by Sectoral Asset Management, T. Rowe Price, Stop Sanfilippo. The meaningful sponsors for the fund in investment in the same round are RBC Capital Markets, Jefferies, TD Securities.

Among the most popular portfolio startups of the fund, we may highlight Redknee, Abeona Therapeutics, Advaxis. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Cantor Fitzgerald performs on 51 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2014. The fund is constantly included in less than 2 investment rounds annually.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
15
Lead investments
2
Exits
7
Rounds per year
0.19
Follow on index
0.07
Investments by industry
  • Biotechnology (3)
  • Health Care (3)
  • Medical Device (3)
  • Medical (3)
  • Health Diagnostics (2)
  • Show 30 more
Investments by region
  • United States (4)
  • Argentina (1)
  • Israel (2)
  • United Kingdom (1)
  • Canada (3)
  • Show 1 more
Peak activity year
2020
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
60M
Group Appearance index
0.73
Avg. company exit year
49

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
HealthBeacon 08 Jan 2019 Health Care, Medical Device, Medical Early Stage Venture 12M County Dublin, Dublin, Ireland
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.